Literature DB >> 2495111

Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7.

R P Cooke1, T Riordan, D M Jones, M J Painter.   

Abstract

To determine the incidence of secondary meningococcal infection in close family and household contacts of index patients and to review the efficacy of chemoprophylaxis the records of 3256 cases occurring from 1984 through 1987 were examined. Seventeen secondary cases (0.5%) of infection were identified among these groups. The median interval between index and secondary cases was seven weeks. Fourteen secondary cases occurred more than one week after the disease was diagnosed in the index case. Three secondary cases had not received chemoprophylaxis and in another case the infecting strain had acquired resistance to rifampicin. Prophylaxis for the close contacts of 10 out of 11 of the remaining index patients failed to fulfil all the criteria of an optimal regimen. Even after optimal chemoprophylaxis the medical practitioner and the family should be aware of the increased and prolonged risk of secondary meningococcal infection among close contacts of patients with the disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495111      PMCID: PMC1835902          DOI: 10.1136/bmj.298.6673.555

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  Rapid serotyping of groups A, B, and C meningococci by rocket-line immunoelectrophoresis and co-agglutination.

Authors:  D Danielsson; P Olcén
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

2.  The carrier state: Neisseria meningitidis.

Authors:  C V Broome
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

Review 3.  The chemoprophylaxis of meningococcal infection.

Authors:  R A Wall
Journal:  J Antimicrob Chemother       Date:  1988-06       Impact factor: 5.790

4.  Spread of meningococcal infection within households.

Authors:  R S Munford; A de E Taunay; J S de Morais; D W Fraser; R A Feldman
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

5.  Serological grouping of meningococci and detection of antigen in cerebrospinal fluid by coagglutination.

Authors:  J Eldridge; E M Sutcliffe; J D Abbott; D M Jones
Journal:  Med Lab Sci       Date:  1978-01

6.  Single-dose ceftriaxone to eradicate pharyngeal Neisseria meningitidis.

Authors:  F N Judson; J M Ehret
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

7.  Meningococcal rash.

Authors:  P Baxter; B Priestley
Journal:  Lancet       Date:  1988-05-21       Impact factor: 79.321

8.  Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis.

Authors:  P N Gaunt; B E Lambert
Journal:  J Antimicrob Chemother       Date:  1988-04       Impact factor: 5.790

9.  An outbreak of meningococcal disease in Stonehouse: planning and execution of a large-scale survey.

Authors:  J M Stuart; K A Cartwright; D M Jones; N D Noah; R J Wall; C C Blackwell; A E Jephcott; I R Ferguson
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

10.  Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts.

Authors:  P De Wals; L Hertoghe; I Borlée-Grimée; S De Maeyer-Cleempoel; G Reginster-Haneuse; A Dachy; A Bouckaert; M F Lechat
Journal:  J Infect       Date:  1981-03       Impact factor: 6.072

  10 in total
  28 in total

1.  Managing meningococcal disease case clusters: art or science?

Authors:  K Ardern; S Bowler; R M Hussey; C M Regan
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

2.  Meningococcal disease and healthcare workers.

Authors:  A J Pollard; N Begg
Journal:  BMJ       Date:  1999-10-30

Review 3.  Recognition, treatment and complications of meningococcal disease.

Authors:  F A Riordan; A P Thomson
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

4.  Meningococcal infections and the general practitioner.

Authors:  D Brewster
Journal:  Br J Gen Pract       Date:  1992-03       Impact factor: 5.386

5.  Genetic diversity of penicillin-binding protein 2 genes of penicillin-resistant strains of Neisseria meningitidis revealed by fingerprinting of amplified DNA.

Authors:  Q Y Zhang; D M Jones; J A Sáez Nieto; E Pérez Trallero; B G Spratt
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

6.  Evidence for indirect nosocomial transmission of Neisseria meningitidis resulting in two cases of invasive meningococcal disease.

Authors:  Johannes Elias; Heike Claus; Matthias Frosch; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

Review 7.  Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review.

Authors:  M R Hoek; H Christensen; W Hellenbrand; P Stefanoff; M Howitz; J M Stuart
Journal:  Epidemiol Infect       Date:  2008-06-18       Impact factor: 2.451

8.  Secondary prevention of meningococcal disease. Penicillin is not recommended in British guidelines.

Authors:  A J Pollard; R Booy; S Nadel; M Levin
Journal:  BMJ       Date:  1996-06-15

9.  Secondary prevention of meningococcal disease. British guidelines should have been considered.

Authors:  D M Jones
Journal:  BMJ       Date:  1996-06-15

10.  Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study.

Authors:  B E Kristiansen; Y Tveten; A Jenkins
Journal:  BMJ       Date:  1998-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.